Abstract
Sickle cell disease (SCD) is a dilapidating disorder that is associated with organ destruction and decreased life expectancy. Therapeutic remedies that lead to fundamental cure of SCD such as, bone marrow and stem cell transplantations, as well as gene replacement therapy, are very costly and unaffordable to the disease sufferers in developing countries. In regions where these therapeutic approaches are possible, there are also limitations such as immunologic transplant rejection, difficulty in prognosis, difficulty in obtaining a suitable donor, end-organ dysfunction, and adverse health effects, especially among the older sufferers of this disease. The eagerness of researchers to develop new drugs for the amelioration of the crisis associated with SCD and a possible cure of the disease has led to the discovery of biomolecular agents that inhibit the mechanisms of HbS polymerization as well as medicinal plants with antisickling potentials. The antisickling potency of medicinal plants should be harnessed through research funding and efforts geared towards the discovery of molecules in such plants with HbS polymerization inhibitory effects.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.